Mental Health News and Research

Latest Mental Health News and Research

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

New smokers more likely to use menthol cigarettes

Menthol cigarette use is higher among persons who started smoking in the past year (44.6 percent) than among longer-term smokers (31.8 percent) according to a new study by the Substance Abuse and Mental Health Services Administration (SAMHSA).

4 Dec 2009

Research study investigates how music therapy can help mentally ill children and young people

Queen's University Belfast is to play a major role in the biggest trial ever conducted to investigate how music therapy can help children and young people with severe mental health problems.

4 Dec 2009

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

African American and Hispanic adults who smoke menthol cigarettes may be less likely to quit smoking than those who smoke regular cigarettes, a new study by researchers at the UMDNJ-School of Public Health has found. The report, published in the December issue of Preventive Medicine, is believed to be the first to use national statistics to examine the association between menthol cigarettes and smoking cessation among adults.

4 Dec 2009

Climate change can cause major impact on global mental health

Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change conference in Copenhagen next week.

4 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

At the beginning of 2010, the Child and Adolescent Psychiatry Department at the Center for Psychosocial Medicine at Heidelberg University Hospital will conduct a study named "Saving and Empowering Young Lives in Europe (SEYLE) - promoting the health of young people through the prevention of risk-taking and self-destructive behavior" in cooperation with twelve centers in other EU countries and Israel.

3 Dec 2009

Macular Health eye vitamin supplement improves visual acuity

Adults are more likely to lose their vision than be diagnosed with cancer. For adults 65 and over, the odds of losing vision are one in three, whereas the odds of a man developing prostate cancer are one in six and odds of a woman developing breast cancer are one in nine. Vision loss threatens the overall health of aging adults by increasing the risk of injuries, depression and inability to complete daily tasks.

3 Dec 2009

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Dr. Julio Montaner - Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society - congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the "Seek and Treat" strategy originally developed at the BC-CfE.

3 Dec 2009

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept, Inc. today announced a collaboration and license agreement for the global development and commercialization of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).

3 Dec 2009

NHLBI approves award of 13 contracts to improve asthma control

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has approved the award of 13 contracts to local organizations across the country to develop, implement, and test science-based approaches to improve asthma control using evidence-based national guidelines for diagnosing and managing asthma.

3 Dec 2009

AclarusDx Alzheimer’s test now available as RUO product

ExonHit Therapeutics is pleased to announce that AclarusDx™ Alzheimer’s test (formerly known as EHT Dx21), its blood-based test for the detection of Alzheimer’s disease (AD), is now available as a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical trials in Alzheimer’s disease.

3 Dec 2009

Latino men adapted to U.S. culture more likely to quit smoking than their less-acculturated counterparts

Latino men who are more adapted to U.S. culture are more likely to quit smoking than their less-acculturated counterparts, according to research by scientists at The University of Texas M. D. Anderson Cancer Center published in the December issue of Cancer Epidemiology, Biomarkers and Prevention, which has a special emphasis on tobacco.

3 Dec 2009

Bavarian Red Cross selects Microcap portable capnographs for RTW medical vehicles

Oridion Systems Ltd. today announced that the Bavarian Red Cross has chosen Microcap(R) portable capnographs for its RTW (Rettungswagen) medical vehicles.

3 Dec 2009

Researchers to publish a paper on the availability of 'Spice' drugs online

A paper to be published this month by University of Hertfordshire researchers about the availability of 'Spice' drugs online will raise new concerns about its mood altering effects.

3 Dec 2009

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.

2 Dec 2009

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

2 Dec 2009

Health eTouch helps to enhance communications between patients and doctors

Parents of teens know just how difficult it is to get them to talk about their personal lives, let alone their health. With only 20 percent of children with mental health problems in the United States being properly identified and treated, it is imperative that a solution be found. Doctors and researchers at Nationwide Children's Hospital are one step closer by finding a new way to get teens to open up about their health and what's really on their mind, bringing up issues that otherwise would have gone unnoticed.

2 Dec 2009

Integrated eating disorders center to be launched shortly

NewYork-Presbyterian Hospital, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, in affiliation with the New York State Psychiatric Institute, announced the creation of an integrated eating disorders center. Opening today is a key clinical component of this new center -- The Outlook at NewYork-Presbyterian Hospital/Westchester Division in White Plains.

2 Dec 2009

New PBS documentary examines why people view happiness as an elusive goal

On the eve of a new year, as millions of Americans struggle to find more meaning in their lives, Vulcan Productions and NOVA/WGBH have teamed up with Harvard psychologist and best-selling author of Stumbling on Happiness, Professor Daniel Gilbert, to produce This Emotional Life. This three-part documentary premieres on PBS January 4-6, 2010 (at 9:00 p.m. check local listings) and examines why people find happiness to be such an elusive goal.

2 Dec 2009

Mental Health News and Research

Latest Mental Health News and Research

FDA approves once-daily SEROQUEL XR Extended Release Tablets

New smokers more likely to use menthol cigarettes

Research study investigates how music therapy can help mentally ill children and young people

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

Climate change can cause major impact on global mental health

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

Macular Health eye vitamin supplement improves visual acuity

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

NHLBI approves award of 13 contracts to improve asthma control

AclarusDx Alzheimer’s test now available as RUO product

Latino men adapted to U.S. culture more likely to quit smoking than their less-acculturated counterparts

Bavarian Red Cross selects Microcap portable capnographs for RTW medical vehicles

Researchers to publish a paper on the availability of 'Spice' drugs online

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Health eTouch helps to enhance communications between patients and doctors

Integrated eating disorders center to be launched shortly

New PBS documentary examines why people view happiness as an elusive goal

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Mental Health News and Research

Latest Mental Health News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in